FBXO7

UniProt ID: Q9Y3I1
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

FBXO7 (also called FBX7; PARK15) is the substrate-recognition (F-box) component of an SCF (SKP1-CUL1-RBX1-F-box) E3 ubiquitin-protein ligase complex, SCF(FBXO7). As an F-box protein it acts as a ligase-substrate adaptor: it recruits substrates and bridges them, via its F-box domain binding to SKP1, to the catalytic cullin-RING core (RBX1), and is not itself the catalytic ubiquitin transferase. The protein has a modular architecture comprising an N-terminal ubiquitin-like (Ubl) region that mediates binding to the E3 ligase PRKN/Parkin, a CDK6-interaction region, an FP (Fbxo7/PI31) dimerization domain that mediates homodimerization and interaction with the proteasome inhibitor PSMF1/PI31, the F-box domain, and a C-terminal proline-rich region that serves as a substrate-binding module. SCF(FBXO7) ubiquitination is not exclusively degradative: it can build K48-linked chains that target substrates for proteasomal degradation or K63-linked chains with non-proteolytic signaling/assembly outcomes, depending on substrate and context. Documented SCF(FBXO7) substrates include the cell-cycle regulator DLGAP5/HURP, the inhibitor-of-apoptosis protein BIRC2/cIAP1, TRAF2 and the NF-kappa-B cofactor UXT isoform 2 (whose degradation inhibits NF-kappa-B signaling), the NAD+-dependent deacetylase SIRT7 (K48- linked polyubiquitination promoting H2O2-induced cell death), the kinase GSK3-beta and the mitochondrial import receptor TOMM20 (modified in part with non-degradative chains), and, in tumor-suppressor contexts, the mitochondrial-fission factor INF2 and the arginine methyltransferase PRMT1 (K48-linked polyubiquitination coupling FBXO7 to control of mitochondrial division and serine biosynthesis, respectively). Beyond canonical SCF activity, FBXO7 has SCF-independent roles: it relocates from the cytosol to depolarized mitochondria downstream of PINK1 and promotes PRKN/Parkin recruitment and mitofusin ubiquitination to drive selective autophagy of damaged mitochondria (mitophagy); it associates with the proteasome and regulates proteasome assembly/activity through PSMF1/PI31; and it activates cyclin D/CDK6 complexes to promote cell-cycle progression, with proto-oncogenic transforming activity. FBXO7 protein stability is itself controlled by the deubiquitinase USP7. FBXO7 is predominantly cytoplasmic/cytosolic with a minor nuclear pool. Recessive loss-of-function and missense mutations (e.g. T22M, R378G, R498X) cause early-onset autosomal recessive parkinsonian-pyramidal syndrome (Parkinson disease 15, PARK15).

Existing Annotations Review

GO Term Evidence Action Reason
GO:1903599 positive regulation of autophagy of mitochondrion
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of a positive role in mitophagy, consistent with the experimentally demonstrated FBXO7 function downstream of PINK1 in Parkin-mediated mitophagy.
Reason: Core biological process; the IBA inference agrees with direct IMP/IDA evidence (PMID:23933751, PMID:26310625) that FBXO7 promotes clearance of depolarized mitochondria.
Supporting Evidence:
PMID:23933751
Here we show that Fbxo7 participates in mitochondrial maintenance through direct interaction with PINK1 and Parkin and acts in Parkin-mediated mitophagy.
file:human/FBXO7/FBXO7-deep-research-falcon.md
FBXO7 participates in mitochondrial quality control by interacting with **PINK1 and Parkin** and facilitating Parkin recruitment to damaged mitochondria in PARK15 biology.
GO:0019901 protein kinase binding
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic assignment of protein kinase binding, reflecting the documented FBXO7 interactions with the kinases CDK6 and PINK1.
Reason: Real and mechanistically meaningful (CDK6 activation of cyclin D complexes; PINK1 in the mitophagy pathway) but a subsidiary binding activity rather than the core adaptor function.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Interacts with CDK6 and promotes its interaction with D-type cyclin.
GO:0005634 nucleus
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Electronic assignment of nuclear localization; FBXO7 has a documented minor nuclear pool in addition to its predominant cytoplasmic localization.
Reason: Nuclear localization is real but minor; the predominant and functionally dominant compartment is the cytoplasm/cytosol.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
A minor proportion is detected in the nucleus (PubMed:16096642).
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: Electronic transfer of cytoplasmic localization from the UniProt subcellular location; the predominant compartment of FBXO7.
Reason: Correct predominant localization, supported experimentally (PMID:16096642, PMID:18495667).
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Note=Predominantly cytoplasmic (PubMed:16096642).
GO:0005739 mitochondrion
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic assignment of mitochondrial localization, consistent with the experimentally observed relocation of FBXO7 from the cytosol to depolarized mitochondria.
Reason: Correct conditional localization; FBXO7 relocates to depolarized mitochondria during mitophagy (PMID:23933751).
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Relocates from the cytosol to depolarized mitochondria (PubMed:23933751).
GO:0005829 cytosol
IEA
GO_REF:0000044
ACCEPT
Summary: Electronic transfer of cytosolic localization from the UniProt subcellular location; the predominant compartment of FBXO7.
Reason: Correct core localization, supported experimentally (PMID:23933751).
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0019901 protein kinase binding
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Electronic assignment of protein kinase binding, reflecting documented CDK6 and PINK1 interactions.
Reason: Real binding activity (CDK6, PINK1) but subsidiary to the core ligase-substrate adaptor function.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Interacts with CDK6 and promotes its interaction with D-type cyclin.
GO:0005515 protein binding
IPI
PMID:16278047
Characterization of FBX25, encoding a novel brain-expressed ...
KEEP AS NON CORE
Summary: Interaction captured during characterization of a related brain-expressed F-box protein (FBX25). Bare protein binding is uninformative.
Reason: Records a real interaction but the bare protein binding term is uninformative per curation guidelines.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:22632967
Cyclin F-mediated degradation of ribonucleotide reductase M2...
KEEP AS NON CORE
Summary: Interaction captured in a cyclin F (FBXO1)/RRM2 study. Bare protein binding is uninformative.
Reason: Records a real interaction but bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:23933751
The Parkinson's disease-linked proteins Fbxo7 and Parkin int...
KEEP AS NON CORE
Summary: Interaction with PRKN/Parkin (and PINK1) from the mitophagy study; a functionally important interaction, but the bare protein binding term is uninformative.
Reason: Records the meaningful FBXO7-PRKN/PINK1 interaction, but bare protein binding is uninformative; the functional relationship is captured by the mitophagy process annotations.
Supporting Evidence:
PMID:23933751
the Ubl domain of Fbxo7 directly mediates Parkin interaction
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
KEEP AS NON CORE
Summary: High-throughput proteome-scale interactome mapping. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative and not a core function.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:25910212
Widespread macromolecular interaction perturbations in human...
KEEP AS NON CORE
Summary: High-throughput interactome perturbation study. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:26496610
A human interactome in three quantitative dimensions organiz...
KEEP AS NON CORE
Summary: High-throughput quantitative interactome map. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:27705803
A High-Density Map for Navigating the Human Polycomb Complex...
KEEP AS NON CORE
Summary: High-throughput Polycomb complexome interaction map. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
KEEP AS NON CORE
Summary: High-throughput interactome (protein communities/disease networks). Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:31515488
Extensive disruption of protein interactions by genetic vari...
KEEP AS NON CORE
Summary: High-throughput variant-interactome disruption study. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative ...
KEEP AS NON CORE
Summary: High-throughput neurodegenerative-disease interactome map. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
KEEP AS NON CORE
Summary: High-throughput dual proteome-scale interactome map. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:0005515 protein binding
IPI
PMID:40205054
Multimodal cell maps as a foundation for structural and func...
KEEP AS NON CORE
Summary: High-throughput multimodal cell-map interactome. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex
GO:1901526 positive regulation of mitophagy
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-based electronic assignment of positive regulation of mitophagy, consistent with the experimentally established FBXO7 mitophagy role.
Reason: Core biological process; agrees with direct experimental evidence (PMID:23933751, PMID:26310625).
Supporting Evidence:
PMID:26310625
The WT FBXO7 protein is vital to cell mitophagy and can facilitate mitophagy to protect cells, whereas mutant FBXO7 inhibits mitophagy.
GO:0016567 protein ubiquitination
IEA
GO_REF:0000041
KEEP AS NON CORE
Summary: UniPathway-derived general protein ubiquitination process, a parent of the specific SCF-dependent catabolic process FBXO7 enables.
Reason: Correct but generic; the specific GO:0031146 (SCF-dependent catabolic process) and K48-linked ubiquitination annotations better capture the role.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
PATHWAY: Protein modification; protein ubiquitination.
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: HPA immunofluorescence assignment of nucleoplasm localization, consistent with the documented minor nuclear pool of FBXO7.
Reason: Real but minor nuclear localization; the predominant compartment is the cytoplasm/cytosol.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
A minor proportion is detected in the nucleus (PubMed:16096642).
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: HPA immunofluorescence assignment of cytosolic localization, the predominant FBXO7 compartment.
Reason: Correct core localization; supported by direct experimental fractionation (PMID:23933751).
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005634 nucleus
EXP
PMID:16096642
Transforming activity of Fbxo7 is mediated specifically thro...
KEEP AS NON CORE
Summary: Experimental localization showing FBXO7 in the nucleus (minor pool) in addition to predominant cytoplasm.
Reason: Real minor nuclear localization documented in this study; predominant compartment is cytoplasmic.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
A minor proportion is detected in the nucleus (PubMed:16096642).
GO:0005737 cytoplasm
EXP
PMID:16096642
Transforming activity of Fbxo7 is mediated specifically thro...
ACCEPT
Summary: Experimental localization showing FBXO7 is predominantly cytoplasmic. Core compartment.
Reason: Core localization with direct experimental support.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Note=Predominantly cytoplasmic (PubMed:16096642).
GO:0005737 cytoplasm
EXP
PMID:18495667
Structure of a conserved dimerization domain within the F-bo...
ACCEPT
Summary: Experimental localization to the cytoplasm consistent with the predominant FBXO7 compartment.
Reason: Core localization with direct experimental support.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm {ECO:0000269|PubMed:16096642, ECO:0000269|PubMed:18495667}.
GO:0019005 SCF ubiquitin ligase complex
NAS
PMID:34445249
The SCF Complex Is Essential to Maintain Genome and Chromoso...
ACCEPT
Summary: Author statement that FBXO7 is an F-box component of an SCF E3 ubiquitin ligase complex. Core complex membership.
Reason: Core localization/complex; FBXO7 is the substrate-receptor F-box subunit of SCF(FBXO7) (CUL1, SKP1, RBX1, FBXO7).
Supporting Evidence:
PMID:34445249
The SKP1, CUL1, F-box protein (SCF) complex encompasses a group of 69 SCF E3 ubiquitin ligase complexes that primarily modify protein substrates with poly-ubiquitin chains to target them for proteasomal degradation.
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
NAS
PMID:34445249
The SCF Complex Is Essential to Maintain Genome and Chromoso...
ACCEPT
Summary: Author statement linking the SCF complex (including F-box proteins) to SCF-dependent proteasomal degradation. Core biological process.
Reason: Core biological process; FBXO7 targets substrates for SCF-dependent proteasomal degradation.
Supporting Evidence:
PMID:34445249
These SCF complexes are distinguishable by variable F-box proteins, which determine substrate specificity.
GO:0005634 nucleus
IDA
PMID:33010352
The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degr...
KEEP AS NON CORE
Summary: Direct evidence that FBXO7 acts in the nucleus, where it colocalizes with and ubiquitinates its substrate UXT-V2.
Reason: Documents a functionally relevant nuclear pool (UXT-V2 degradation) but nuclear localization is minor relative to the predominant cytoplasm/cytosol.
Supporting Evidence:
PMID:33010352
We find that UXT-V2 colocalizes with Fbxo7 in the cell nucleus.
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
IDA
PMID:33010352
The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degr...
ACCEPT
Summary: Direct evidence that SCF(FBXO7) mediates SCF-dependent proteasomal degradation of UXT-V2. Core biological process.
Reason: Core biological process with direct experimental support; SCF(FBXO7) polyubiquitinates UXT-V2 for proteasomal degradation.
Supporting Evidence:
PMID:33010352
Together, our study reveals that SCF(Fbxo7) mediates the proteasomal degradation of UXT-V2 causing the inhibition of the NF-ΞΊB signaling pathway.
GO:0043124 negative regulation of canonical NF-kappaB signal transduction
IDA
PMID:33010352
The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degr...
ACCEPT
Summary: Direct evidence that SCF(FBXO7)-mediated degradation of UXT-V2 inhibits NF-kappa-B signaling. Well-supported biological process.
Reason: Directly demonstrated; FBXO7 negatively regulates NF-kappa-B signaling via UXT-V2 (and TRAF2/cIAP1) ubiquitination.
Supporting Evidence:
PMID:33010352
Together, our study reveals that SCF(Fbxo7) mediates the proteasomal degradation of UXT-V2 causing the inhibition of the NF-ΞΊB signaling pathway.
GO:0070936 protein K48-linked ubiquitination
IDA
PMID:33010352
The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degr...
ACCEPT
Summary: Direct evidence that SCF(FBXO7) builds K48 (and K63) polyubiquitin chains on UXT-V2.
Reason: Directly demonstrated K48-linked ubiquitination of a substrate, the canonical degradative topology used by SCF(FBXO7).
Supporting Evidence:
PMID:33010352
This substrate is polyubiquitinated by SCF(Fbxo7) with K48 and K63 ubiquitin chain linkages in vitro and in vivo.
GO:1901526 positive regulation of mitophagy
IDA
PMID:26310625
F-box protein 7 mutations promote protein aggregation in mit...
ACCEPT
Summary: Direct evidence that WT FBXO7 facilitates mitophagy whereas PD-linked mutants inhibit it. Core biological process.
Reason: Core biological process with direct experimental support.
Supporting Evidence:
PMID:26310625
The WT FBXO7 protein is vital to cell mitophagy and can facilitate mitophagy to protect cells, whereas mutant FBXO7 inhibits mitophagy.
GO:1903377 negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway
IMP
PMID:25029497
FBXO7 Y52C polymorphism as a potential protective factor in ...
KEEP AS NON CORE
Summary: Mutant-phenotype evidence linking an FBXO7 variant (Y52C) to altered TRAF2 turnover and neuronal outgrowth in a PD-protective context.
Reason: A context-specific neuronal stress/apoptosis-modulating role inferred from variant phenotypes, not the core SCF adaptor function.
Supporting Evidence:
PMID:25029497
After induced differentiation, SH-SY5Y cells expressing Cys52 FBXO7 displayed increased neuronal outgrowth.
GO:1903377 negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway
IDA
PMID:26310625
F-box protein 7 mutations promote protein aggregation in mit...
KEEP AS NON CORE
Summary: Evidence that FBXO7 acts as a stress-response protein with cytoprotective (and, when mutant/aggregated, neurotoxic) effects under oxidative stress.
Reason: A context-specific neuronal stress-response role; mechanistically downstream of the core mitophagy/proteostasis functions rather than a distinct core process.
Supporting Evidence:
PMID:26310625
Here we demonstrated that wild-type (WT) FBXO7 is a stress response protein and it can play both cytoprotective and neurotoxic roles.
GO:0005634 nucleus
IDA
PMID:36646384
E3 ligase adaptor FBXO7 contributes to ubiquitination and pr...
KEEP AS NON CORE
Summary: Direct evidence that FBXO7 colocalizes with its substrate SIRT7 mainly in the nucleus, where it acts to degrade SIRT7.
Reason: Documents a functionally relevant nuclear pool (SIRT7 degradation) but nuclear localization is minor relative to the predominant cytoplasm/cytosol.
Supporting Evidence:
PMID:36646384
immunohistochemical analysis of SH-SY5Y cells revealed that endogenous FBXO7 and SIRT7 colocalized mainly in the nucleus
GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process
IDA
PMID:36646384
E3 ligase adaptor FBXO7 contributes to ubiquitination and pr...
ACCEPT
Summary: Direct evidence that FBXO7 drives SCF-dependent proteasomal degradation of SIRT7. Core biological process.
Reason: Core biological process; FBXO7 promotes proteasomal degradation of SIRT7 (the more specific GO:0031146 SCF-dependent process is also annotated).
Supporting Evidence:
PMID:36646384
we identified FBXO7 as a novel E3 ligase for SIRT7 that negatively regulates intracellular SIRT7 levels through SCF-dependent Lys-48-linked polyubiquitination and proteasomal degradation
GO:0070936 protein K48-linked ubiquitination
IDA
PMID:36646384
E3 ligase adaptor FBXO7 contributes to ubiquitination and pr...
ACCEPT
Summary: Direct evidence that FBXO7 promotes K48-linked polyubiquitination of SIRT7.
Reason: Directly demonstrated K48-linked ubiquitination of a substrate (SIRT7), the canonical degradative topology of SCF(FBXO7).
Supporting Evidence:
PMID:36646384
These results demonstrated that FBXO7 directly mediates the polyubiquitination of SIRT7 by targeting K48-linked polyubiquitin chains.
GO:1990756 ubiquitin-like ligase-substrate adaptor activity
IDA
PMID:36646384
E3 ligase adaptor FBXO7 contributes to ubiquitination and pr...
ACCEPT
Summary: Direct evidence that FBXO7 acts as an SCF substrate-recognition adaptor recruiting SIRT7 for ubiquitination. Core molecular function.
Reason: Core molecular function; FBXO7 is the substrate-recognition adaptor of SCF(FBXO7), bridging substrates to the catalytic cullin-RING core.
Supporting Evidence:
PMID:36646384
FBXO7 is an adaptor protein in the SKP1-Cullin-1-F-box (SCF) E3 ligase complex that facilitates the ubiquitination of substrates.
GO:0019005 SCF ubiquitin ligase complex
IDA
PMID:15145941
Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-p...
ACCEPT
Summary: Direct evidence that FBXO7 functions within an SCF(FBXO7) complex (with SKP1 and CUL1) to ubiquitinate HURP/DLGAP5. Core complex membership.
Reason: Core localization/complex; FBXO7 is a functional F-box subunit of an SCF ubiquitin-ligase complex.
Supporting Evidence:
PMID:15145941
In the SCF(Fbx7) complex, Fbx7 recruits HURP through its C-terminal proline-rich region in a Cdk1-cyclin B-phosphorylation dependent manner.
GO:1990756 ubiquitin-like ligase-substrate adaptor activity
IDA
PMID:15145941
Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-p...
ACCEPT
Summary: Direct evidence that FBXO7 functions as a substrate-recruiting adaptor of the SCF complex, binding HURP via its proline-rich region. Core molecular function.
Reason: Core molecular function; FBXO7 is a functional SCF adaptor with the proline-rich region serving as the substrate-binding module.
Supporting Evidence:
PMID:15145941
Thus, Fbx7 is a functional adaptor of the SCF complex with a proline-rich region as the substrate-binding module.
GO:0005515 protein binding
IPI
PMID:21378169
A Competitive binding mechanism between Skp1 and exportin 1 ...
KEEP AS NON CORE
Summary: Interaction captured in a study of SKP1/CRM1 competition controlling F-box protein localization. Bare protein binding is uninformative.
Reason: Records a real interaction relevant to FBXO7 nuclear/cytoplasmic shuttling (SKP1, CRM1) but bare protein binding is uninformative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Part of the SCF (SKP1-CUL1-F-box) E3 ubiquitin-protein ligase complex SCF(FBXO7) formed of CUL1, SKP1, RBX1 and FBXO7.
GO:0005739 mitochondrion
IDA
PMID:26310625
F-box protein 7 mutations promote protein aggregation in mit...
ACCEPT
Summary: Direct evidence that FBXO7 concentrates into mitochondria upon stress, forming aggregates. Conditional/stress-induced localization.
Reason: Correct conditional localization; FBXO7 relocates to mitochondria under stress/depolarization, consistent with its mitophagy role.
Supporting Evidence:
PMID:26310625
Upon stress, the endogenous WT FBXO7 gets up-regulated, concentrates into mitochondria and forms FBXO7 aggregates in mitochondria.
GO:0005515 protein binding
IPI
PMID:25029497
FBXO7 Y52C polymorphism as a potential protective factor in ...
KEEP AS NON CORE
Summary: Interaction with TRAF2 captured in the FBXO7 Y52C polymorphism study. Bare protein binding is uninformative.
Reason: Records the functionally meaningful FBXO7-TRAF2 interaction but bare protein binding is uninformative; the substrate relationship is captured by the ubiquitination/NF-kappa-B annotations.
Supporting Evidence:
PMID:25029497
Moreover, Cys52 FBXO7 showed stronger interaction with TRAF2 and promoted TRAF2 ubiquitination
GO:0005634 nucleus
IDA
PMID:16510124
The F-box protein Fbxo7 interacts with human inhibitor of ap...
KEEP AS NON CORE
Summary: Direct evidence of FBXO7 nuclear localization (colocalized with cIAP1/BIRC2 in cytoplasm and nucleus). Minor nuclear pool.
Reason: Real but minor nuclear localization; predominant compartment is cytoplasm/cytosol.
Supporting Evidence:
PMID:16510124
When co-expressed in cells, cIAP1 and Fbxo7 co-localized remarkably both in the cytoplasm and nucleus
GO:0005634 nucleus
IDA
PMID:25029497
FBXO7 Y52C polymorphism as a potential protective factor in ...
KEEP AS NON CORE
Summary: Direct evidence of FBXO7 nuclear localization, consistent with the documented minor nuclear pool.
Reason: Real but minor nuclear localization; predominant compartment is cytoplasm/cytosol.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
A minor proportion is detected in the nucleus (PubMed:16096642).
GO:0005737 cytoplasm
IDA
PMID:16510124
The F-box protein Fbxo7 interacts with human inhibitor of ap...
ACCEPT
Summary: Direct evidence of FBXO7 cytoplasmic localization (colocalized with cIAP1/BIRC2). Core compartment.
Reason: Core localization with direct experimental support.
Supporting Evidence:
PMID:16510124
When co-expressed in cells, cIAP1 and Fbxo7 co-localized remarkably both in the cytoplasm and nucleus
GO:0005737 cytoplasm
IDA
PMID:25029497
FBXO7 Y52C polymorphism as a potential protective factor in ...
ACCEPT
Summary: Direct evidence of FBXO7 cytoplasmic localization. Core compartment.
Reason: Core localization with direct experimental support.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Note=Predominantly cytoplasmic (PubMed:16096642).
GO:0006511 ubiquitin-dependent protein catabolic process
IDA
PMID:25029497
FBXO7 Y52C polymorphism as a potential protective factor in ...
KEEP AS NON CORE
Summary: Direct evidence that FBXO7 promotes ubiquitination and turnover of TRAF2. A parent of the more specific SCF-dependent catabolic process.
Reason: Correct but generic relative to the specific GO:0031146 (SCF-dependent proteasomal catabolic process); here the substrate is TRAF2.
Supporting Evidence:
PMID:25029497
In cells expressing Cys52 FBXO7, the level of TNF receptor-associated factor 2 (TRAF2) was significantly reduced.
GO:0010975 regulation of neuron projection development
IMP
PMID:25029497
FBXO7 Y52C polymorphism as a potential protective factor in ...
KEEP AS NON CORE
Summary: Mutant-phenotype evidence that an FBXO7 variant alters neuronal outgrowth in differentiated SH-SY5Y cells.
Reason: A context-specific neuronal phenotype linked to an FBXO7 variant, not the core SCF adaptor function.
Supporting Evidence:
PMID:25029497
After induced differentiation, SH-SY5Y cells expressing Cys52 FBXO7 displayed increased neuronal outgrowth.
GO:0016567 protein ubiquitination
IDA
PMID:16510124
The F-box protein Fbxo7 interacts with human inhibitor of ap...
KEEP AS NON CORE
Summary: Direct evidence that FBXO7 overexpression promotes ubiquitination of cIAP1/BIRC2. Generic parent process.
Reason: Correct but generic; the specific SCF-dependent catabolic process (GO:0031146) better captures the role. The cIAP1/BIRC2 substrate relationship is meaningful.
Supporting Evidence:
PMID:16510124
Furthermore, we showed that overexpression of Fbxo7 promotes the ubiquitination of cIAP1.
GO:0019901 protein kinase binding
IPI
PMID:18495667
Structure of a conserved dimerization domain within the F-bo...
KEEP AS NON CORE
Summary: Interaction with the kinase CDK6 (and PSMF1) documented in the FP-domain structural study.
Reason: Real CDK6 binding (FBXO7 activates cyclin D-CDK6) but subsidiary to the core adaptor function.
Supporting Evidence:
PMID:18495667
SCF(Fbxo7) is known to catalyze the ubiquitination of hepatoma-up-regulated protein (HURP) and the inhibitor of apoptosis (IAP) protein but also functions as an activator of cyclin D-Cdk6 complexes.
GO:0031625 ubiquitin protein ligase binding
IPI
PMID:16510124
The F-box protein Fbxo7 interacts with human inhibitor of ap...
KEEP AS NON CORE
Summary: Interaction with the ubiquitin ligase cIAP1/BIRC2 (itself a RING E3) documented as an FBXO7 substrate interaction.
Reason: Records a real interaction with a ubiquitin ligase substrate (BIRC2) but is subsidiary to the core adaptor function.
Supporting Evidence:
PMID:16510124
we performed a yeast two-hybrid screen and identified an F-box protein Fbxo7 as a cIAP1 interacting protein.
GO:0043130 ubiquitin binding
IDA
PMID:25029497
FBXO7 Y52C polymorphism as a potential protective factor in ...
KEEP AS NON CORE
Summary: Assignment of ubiquitin binding to FBXO7. A plausible but ancillary activity relative to the core substrate-adaptor function.
Reason: If accurate, ubiquitin binding is a subsidiary molecular feature; the core function is the ligase-substrate adaptor activity. Not central to the documented FBXO7 roles.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
The ubiquitin-like region mediates interaction with PRKN.
GO:0046982 protein heterodimerization activity
IPI
PMID:18495667
Structure of a conserved dimerization domain within the F-bo...
KEEP AS NON CORE
Summary: Direct evidence that FBXO7 heterodimerizes with PSMF1/PI31 via the shared FP domain (and homodimerizes).
Reason: Real FP-domain-mediated dimerization with PSMF1/PI31 (relevant to proteasome regulation) but a structural/binding property rather than the core adaptor function.
Supporting Evidence:
PMID:18495667
We identify PI31 as an Fbxo7.Skp1 binding partner and show that this interaction requires an N-terminal domain present in both proteins that we term the FP (Fbxo7/PI31) domain.
GO:0005634 nucleus
IDA
PMID:21347293
Loss of nuclear activity of the FBXO7 protein in patients wi...
KEEP AS NON CORE
Summary: Direct evidence that wild-type FBXO7 isoform 1 displays mostly diffuse nuclear localization, with loss of nuclear localization in PARK15 mutants.
Reason: This study emphasizes a nuclear pool, but UniProt and other studies establish that FBXO7 is predominantly cytoplasmic; nuclear localization is treated as non-core.
Supporting Evidence:
PMID:21347293
the endogenous or over-expressed, wild type FBXO7 isoform 1 displays mostly a diffuse nuclear localization
GO:0005737 cytoplasm
IDA
PMID:21347293
Loss of nuclear activity of the FBXO7 protein in patients wi...
ACCEPT
Summary: Direct evidence of FBXO7 cytoplasmic localization, including mutant-induced cytoplasmic mislocalization. Core compartment.
Reason: Core localization with direct experimental support; PARK15 N-terminal mutations shift FBXO7 to the cytoplasm.
Supporting Evidence:
PMID:21347293
N-terminal modification by PARK15-linked missense mutation, or N-terminus tag leads to cytoplasmic mislocalization
GO:0005634 nucleus
IDA
PMID:23656991
FBXO7 immunoreactivity in Ξ±-synuclein-containing inclusions ...
KEEP AS NON CORE
Summary: Immunohistochemical detection of FBXO7 in human brain neurons; widespread expression. Reported nuclear/cytoplasmic neuronal staining.
Reason: Brain immunoreactivity localization; nuclear pool is minor relative to predominant cytoplasm.
Supporting Evidence:
PMID:23656991
We detected widespread brain FBXO7 immunoreactivity, with the highest levels in neurons of the cerebral cortex, putamen, and cerebellum.
GO:0005737 cytoplasm
IDA
PMID:23656991
FBXO7 immunoreactivity in Ξ±-synuclein-containing inclusions ...
ACCEPT
Summary: Immunohistochemical detection of FBXO7 in the cytoplasm of human brain neurons. Consistent with predominant cytoplasmic localization.
Reason: Consistent with the core cytoplasmic localization of FBXO7 in neurons.
Supporting Evidence:
PMID:23656991
We detected widespread brain FBXO7 immunoreactivity, with the highest levels in neurons of the cerebral cortex, putamen, and cerebellum.
GO:0019005 SCF ubiquitin ligase complex
TAS
PMID:16510124
The F-box protein Fbxo7 interacts with human inhibitor of ap...
ACCEPT
Summary: Author statement that F-box proteins such as FBXO7 are specificity-determining subunits of SCF ubiquitin ligases. Core complex membership.
Reason: Core localization/complex; FBXO7 is the F-box substrate-receptor subunit of an SCF E3 ligase.
Supporting Evidence:
PMID:16510124
Since F-box proteins are specificity determining subunits of SCF ubiquitin protein ligases, our results suggest that Fbxo7 can mediate the ubiquitination of cIAP1 by SCF ubiquitin protein ligase
GO:0097409 glial cytoplasmic inclusion
IDA
PMID:23656991
FBXO7 immunoreactivity in Ξ±-synuclein-containing inclusions ...
KEEP AS NON CORE
Summary: Direct immunoreactivity for FBXO7 within alpha-synuclein-positive glial cytoplasmic inclusions in multiple system atrophy. A disease-pathology localization.
Reason: Real IDA immunoreactivity in pathological inclusions, but this is a disease-associated localization, not a core physiological compartment.
Supporting Evidence:
PMID:23656991
FBXO7 immunoreactivity was detected in large proportions of Ξ±-synuclein-positive inclusions (Lewy bodies, Lewy neurites, glial cytoplasmic inclusions)
GO:0097414 classical Lewy body
IDA
PMID:23656991
FBXO7 immunoreactivity in Ξ±-synuclein-containing inclusions ...
KEEP AS NON CORE
Summary: Direct immunoreactivity for FBXO7 within alpha-synuclein-positive Lewy bodies in Parkinson disease. A disease-pathology localization.
Reason: Real IDA immunoreactivity in pathological inclusions, but a disease-associated localization, not a core physiological compartment.
Supporting Evidence:
PMID:23656991
FBXO7 immunoreactivity was detected in large proportions of Ξ±-synuclein-positive inclusions (Lewy bodies, Lewy neurites, glial cytoplasmic inclusions)
GO:0097462 Lewy neurite
IDA
PMID:23656991
FBXO7 immunoreactivity in Ξ±-synuclein-containing inclusions ...
KEEP AS NON CORE
Summary: Direct immunoreactivity for FBXO7 within alpha-synuclein-positive Lewy neurites. A disease-pathology localization.
Reason: Real IDA immunoreactivity in pathological inclusions, but a disease-associated localization, not a core physiological compartment.
Supporting Evidence:
PMID:23656991
FBXO7 immunoreactivity was detected in large proportions of Ξ±-synuclein-positive inclusions (Lewy bodies, Lewy neurites, glial cytoplasmic inclusions)
GO:1990037 Lewy body core
IDA
PMID:23656991
FBXO7 immunoreactivity in Ξ±-synuclein-containing inclusions ...
KEEP AS NON CORE
Summary: Direct immunoreactivity for FBXO7 colocalizing with alpha-synuclein in Lewy body structures. A disease-pathology localization.
Reason: Real IDA immunoreactivity in pathological inclusions, but a disease-associated localization, not a core physiological compartment.
Supporting Evidence:
PMID:23656991
where it colocalized with Ξ±-synuclein in PD and MSA cases
GO:1990038 Lewy body corona
IDA
PMID:23656991
FBXO7 immunoreactivity in Ξ±-synuclein-containing inclusions ...
KEEP AS NON CORE
Summary: Direct immunoreactivity for FBXO7 colocalizing with alpha-synuclein in Lewy body structures. A disease-pathology localization.
Reason: Real IDA immunoreactivity in pathological inclusions, but a disease-associated localization, not a core physiological compartment.
Supporting Evidence:
PMID:23656991
where it colocalized with Ξ±-synuclein in PD and MSA cases
GO:0005634 nucleus
IDA
PMID:21378169
A Competitive binding mechanism between Skp1 and exportin 1 ...
KEEP AS NON CORE
Summary: Direct evidence relating to FBXO7 nuclear/cytoplasmic distribution governed by SKP1/CRM1 competition.
Reason: Real but minor nuclear localization governed by SKP1/CRM1 shuttling; predominant compartment is cytoplasm.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
A minor proportion is detected in the nucleus (PubMed:16096642).
GO:0005737 cytoplasm
IDA
PMID:21378169
A Competitive binding mechanism between Skp1 and exportin 1 ...
ACCEPT
Summary: Direct evidence of FBXO7 cytoplasmic localization controlled by SKP1/CRM1 competition. Core compartment.
Reason: Core localization with direct experimental support.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Note=Predominantly cytoplasmic (PubMed:16096642).
GO:0040012 regulation of locomotion
IDA
PMID:26310625
F-box protein 7 mutations promote protein aggregation in mit...
KEEP AS NON CORE
Summary: Organismal locomotor phenotype associated with FBXO7 (Drosophila dopamine-neuron degeneration and PD-related models), reflecting its mitophagy/neuroprotection role.
Reason: An organismal/neurodegeneration phenotype downstream of the core mitophagy function rather than a distinct cell-autonomous core process.
Supporting Evidence:
PMID:26310625
The overexpression of WT FBXO7 could lead to FBXO7 protein aggregation and dopamine neuron degeneration in transgenic Drosophila heads.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8952618
ACCEPT
Summary: Reactome neddylation/CRL-machinery pathway annotation placing FBXO7 in the cytosol. The cytosol is the predominant FBXO7 compartment.
Reason: Correct core localization; cytosol is the predominant compartment for the SCF(FBXO7) complex.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8952620
ACCEPT
Summary: Reactome CRL-machinery pathway annotation placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8955241
ACCEPT
Summary: Reactome CRL-machinery pathway annotation (CAND1 binding) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8955289
ACCEPT
Summary: Reactome CRL-machinery pathway annotation (COMMD/CAND1) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8956040
ACCEPT
Summary: Reactome CRL-machinery pathway annotation (COP9 signalosome deneddylation) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8956200
ACCEPT
Summary: Reactome CRL-machinery pathway annotation (DCUN1D3) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-983140
ACCEPT
Summary: Reactome ubiquitination-pathway annotation (Ub transfer from E2 to substrate) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-983147
ACCEPT
Summary: Reactome ubiquitination-pathway annotation (release of E3 from polyubiquitinated substrate) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-983156
ACCEPT
Summary: Reactome ubiquitination-pathway annotation (polyubiquitination of substrate) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005829 cytosol
TAS
Reactome:R-HSA-983157
ACCEPT
Summary: Reactome ubiquitination-pathway annotation (interaction of E3 with substrate and E2-Ub complex) placing FBXO7 in the cytosol.
Reason: Correct core localization; cytosol is the predominant compartment.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm, cytosol {ECO:0000269|PubMed:23933751}.
GO:0005634 nucleus
IDA
PMID:18495667
Structure of a conserved dimerization domain within the F-bo...
KEEP AS NON CORE
Summary: Direct evidence of FBXO7 nuclear localization documented in the FP-domain study. Minor nuclear pool.
Reason: Real but minor nuclear localization; predominant compartment is cytoplasm/cytosol.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Nucleus {ECO:0000269|PubMed:16096642, ECO:0000269|PubMed:18495667, ECO:0000269|PubMed:33010352}.
GO:0005829 cytosol
IDA
PMID:18495667
Structure of a conserved dimerization domain within the F-bo...
ACCEPT
Summary: Direct evidence of FBXO7 cytosolic localization. Core compartment.
Reason: Core localization with direct experimental support.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Cytoplasm {ECO:0000269|PubMed:16096642, ECO:0000269|PubMed:18495667}.
GO:0000151 ubiquitin ligase complex
IDA
PMID:23933751
The Parkinson's disease-linked proteins Fbxo7 and Parkin int...
KEEP AS NON CORE
Summary: Direct evidence that FBXO7 is part of a ubiquitin ligase complex (the SCF(FBXO7) complex). Generic parent of the specific SCF complex term.
Reason: Correct but generic; the more specific GO:0019005 (SCF ubiquitin ligase complex) better captures FBXO7's complex membership.
Supporting Evidence:
PMID:23933751
F-box domain-containing proteins target substrates to SCF-type (Skp1-Cul1-F-box) E3-ubiquitin ligase complexes
GO:0000422 autophagy of mitochondrion
IMP
PMID:23933751
The Parkinson's disease-linked proteins Fbxo7 and Parkin int...
ACCEPT
Summary: Mutant-phenotype evidence that reducing FBXO7 impairs CCCP-induced mitophagy and that FBXO7 acts in Parkin-mediated mitophagy. Core biological process.
Reason: Core biological process with direct experimental (IMP) support; FBXO7 knockdown reduces mitophagy and FBXO7 rescues parkin mutant phenotypes.
Supporting Evidence:
PMID:23933751
Cells with reduced Fbxo7 expression showed deficiencies in translocation of Parkin to mitochondria, ubiquitination of mitofusin 1 and mitophagy.
GO:0005739 mitochondrion
IDA
PMID:23933751
The Parkinson's disease-linked proteins Fbxo7 and Parkin int...
ACCEPT
Summary: Direct evidence that FBXO7 relocates from the cytosol to depolarized mitochondria following CCCP treatment. Conditional localization.
Reason: Correct conditional/stress-induced localization central to the mitophagy function.
Supporting Evidence:
PMID:23933751
endogenous Fbxo7 levels were found to decrease steadily in the cytosolic fraction and increase concurrently in the mitochondrial fractions
GO:0005829 cytosol
IDA
PMID:23933751
The Parkinson's disease-linked proteins Fbxo7 and Parkin int...
ACCEPT
Summary: Direct evidence that FBXO7 is predominantly cytosolic (before relocating to depolarized mitochondria). Core compartment.
Reason: Core localization with direct experimental support (cell fractionation).
Supporting Evidence:
PMID:23933751
although both proteins localise predominantly to the cytosol
GO:0016567 protein ubiquitination
IMP
PMID:23933751
The Parkinson's disease-linked proteins Fbxo7 and Parkin int...
KEEP AS NON CORE
Summary: Mutant-phenotype evidence that FBXO7 is required for CCCP-induced mitofusin 1 ubiquitination (via promoting Parkin recruitment). Generic parent process.
Reason: Correct but generic; FBXO7 facilitates substrate (Mfn1) ubiquitination chiefly by promoting Parkin recruitment. The specific mitophagy annotations better capture the role.
Supporting Evidence:
PMID:23933751
Cells with reduced Fbxo7 expression showed deficiencies in translocation of Parkin to mitochondria, ubiquitination of mitofusin 1 and mitophagy.
GO:0070585 protein localization to mitochondrion
IMP
PMID:23933751
The Parkinson's disease-linked proteins Fbxo7 and Parkin int...
ACCEPT
Summary: Mutant-phenotype evidence that FBXO7 is required for Parkin translocation to depolarized mitochondria. Well-supported process.
Reason: Directly demonstrated; FBXO7 facilitates Parkin recruitment to mitochondria, a key step in mitophagy.
Supporting Evidence:
PMID:23933751
Overall, these data indicate that Fbxo7 facilitates Parkin translocation to the mitochondria in response to depolarisation.
GO:0032991 protein-containing complex
IDA
GO_REF:0000054
KEEP AS NON CORE
Summary: LIFEdb fusion-protein localization assignment of generic protein-containing complex membership.
Reason: Correct but generic; the specific SCF ubiquitin ligase complex (GO:0019005) is far more informative.
Supporting Evidence:
file:human/FBXO7/FBXO7-uniprot.txt
Part of the SCF (SKP1-CUL1-F-box) E3 ubiquitin-protein ligase complex SCF(FBXO7) formed of CUL1, SKP1, RBX1 and FBXO7.
GO:0031647 regulation of protein stability
IDA
PMID:15145941
Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-p...
KEEP AS NON CORE
Summary: Direct evidence that FBXO7 controls the stability/abundance of its substrate HURP via ubiquitination.
Reason: Correct but generic; FBXO7 regulates substrate stability through the more specific SCF-dependent catabolic process (GO:0031146).
Supporting Evidence:
PMID:15145941
Depletion of Fbx7 by small interfering RNA leads to depression of HURP ubiquitination and accumulation of HURP abundance.
GO:0005515 protein binding
IPI
PMID:15145941
Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-p...
KEEP AS NON CORE
Summary: Interaction with the substrate DLGAP5/HURP (and CUL1/SKP1) from the HURP proteolysis study. Bare protein binding is uninformative.
Reason: Records the meaningful FBXO7-HURP/DLGAP5 substrate interaction, but bare protein binding is uninformative; captured by the SCF/adaptor annotations.
Supporting Evidence:
PMID:15145941
In the SCF(Fbx7) complex, Fbx7 recruits HURP through its C-terminal proline-rich region in a Cdk1-cyclin B-phosphorylation dependent manner.
GO:0000151 ubiquitin ligase complex
TAS
PMID:10531035
Identification of a family of human F-box proteins.
KEEP AS NON CORE
Summary: Author statement that F-box proteins are subunits of SCF ubiquitin protein ligases. Generic parent of the SCF complex term.
Reason: Correct but generic; the more specific GO:0019005 (SCF ubiquitin ligase complex) better captures FBXO7's membership.
Supporting Evidence:
PMID:10531035
In fact, F-box proteins are one of the four subunits of ubiquitin protein ligases called SCFs.
GO:0004842 ubiquitin-protein transferase activity
TAS
PMID:10531035
Identification of a family of human F-box proteins.
MODIFY
Summary: Family-level author statement assigning ubiquitin-protein transferase activity to F-box-containing SCF ligases. FBXO7 is the substrate-recognition adaptor, not the catalytic transferase (the catalytic RING is RBX1).
Reason: FBXO7 itself is not the ubiquitin transferase; it is the substrate-recognition adaptor of the SCF complex. The catalytic transfer is performed by the E2 recruited by the RBX1 RING. The informative molecular function is the ligase-substrate adaptor activity.
Supporting Evidence:
PMID:36646384
FBXO7 is an adaptor protein in the SKP1-Cullin-1-F-box (SCF) E3 ligase complex that facilitates the ubiquitination of substrates.
GO:0006511 ubiquitin-dependent protein catabolic process
TAS
PMID:10531035
Identification of a family of human F-box proteins.
KEEP AS NON CORE
Summary: Family-level author statement that F-box/SCF proteins drive controlled degradation of cellular regulatory proteins. Generic parent of the specific SCF-dependent process.
Reason: Correct but generic; the specific GO:0031146 (SCF-dependent proteasomal catabolic process) better captures FBXO7's role.
Supporting Evidence:
PMID:10531035
Some F-box proteins have been shown to be critical for the controlled degradation of cellular regulatory proteins

Core Functions

Substrate-recognition (F-box) adaptor of the SCF(FBXO7) E3 ubiquitin ligase complex (CUL1-SKP1-RBX1-FBXO7) that recruits substrates (e.g. DLGAP5/HURP, BIRC2/cIAP1, TRAF2, UXT-V2, SIRT7) via its proline-rich region and Ubl/FP regions and bridges them to the catalytic cullin-RING core for K48-linked polyubiquitination and proteasomal degradation.

Supporting Evidence:
  • PMID:36646384
    FBXO7 is an adaptor protein in the SKP1-Cullin-1-F-box (SCF) E3 ligase complex that facilitates the ubiquitination of substrates.
  • PMID:15145941
    Thus, Fbx7 is a functional adaptor of the SCF complex with a proline-rich region as the substrate-binding module.

SCF-independent regulator of mitophagy that relocates from the cytosol to depolarized mitochondria downstream of PINK1, interacts with PINK1 and PRKN/Parkin via its N-terminal Ubl region, and promotes Parkin recruitment to mitochondria and mitofusin ubiquitination to drive selective autophagic clearance of damaged mitochondria.

Supporting Evidence:
  • PMID:23933751
    Here we show that Fbxo7 participates in mitochondrial maintenance through direct interaction with PINK1 and Parkin and acts in Parkin-mediated mitophagy.

Negative regulator of canonical NF-kappa-B signaling, achieved by SCF(FBXO7)-mediated K48/K63 polyubiquitination and proteasomal degradation of the NF-kappa-B cofactor UXT isoform 2 (and ubiquitination of TRAF2 and cIAP1/BIRC2).

Supporting Evidence:
  • PMID:33010352
    Together, our study reveals that SCF(Fbxo7) mediates the proteasomal degradation of UXT-V2 causing the inhibition of the NF-ΞΊB signaling pathway.

Proteasome-associated regulator of proteostasis that, through FP-domain heterodimerization with the proteasome inhibitor PSMF1/PI31 and ubiquitin signaling on proteasomal components, tunes 26S proteasome assembly/activity; loss of FBXO7 reduces proteasome activity and models a parkinsonism-like phenotype, indicating a role in neuronal proteostasis.

Cellular Locations:
Supporting Evidence:
  • PMID:18495667
    We identify PI31 as an Fbxo7.Skp1 binding partner and show that this interaction requires an N-terminal domain present in both proteins that we term the FP (Fbxo7/PI31) domain.
  • file:human/FBXO7/FBXO7-deep-research-falcon.md
    In mouse models, **loss of Fbxo7** leads to **reduced proteasome activity** and a **parkinsonism-like phenotype**, supporting a role for FBXO7 in neuronal proteostasis.

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: To what extent are FBXO7's SCF-dependent substrate-degradation roles (HURP, cIAP1, TRAF2, UXT-V2, SIRT7) and its SCF-independent roles (PINK1/Parkin mitophagy, PSMF1/PI31 proteasome regulation, cyclin D/CDK6 activation) separable, and which are most relevant to PARK15 neurodegeneration?

Q: How do the FP domain-mediated FBXO7 homodimerization and FBXO7-PSMF1/PI31 heterodimerization regulate proteasome assembly/activity in neurons, and is this disrupted by PARK15 mutations?

Q: Does FBXO7 directly target PRKN/PINK1 for ubiquitination, or does it act mainly as a non-catalytic scaffold promoting Parkin recruitment to depolarized mitochondria?

Suggested Experiments

Experiment: Reconstitute SCF(FBXO7) in vitro with purified CUL1, SKP1, RBX1, an E2, and candidate substrates (HURP/DLGAP5, SIRT7, UXT-V2) to confirm that FBXO7 functions as a substrate-presenting adaptor (not the catalytic transferase) and to map substrate lysines and chain linkages.

Experiment: Perform quantitative ubiquitinome and proteome profiling in FBXO7-knockout versus wild-type neuronal cells under basal and mitochondrial-depolarization (CCCP) conditions to define the endogenous SCF(FBXO7) substrate repertoire and its contribution to mitophagy.

Experiment: Use live-cell imaging with PARK15 patient-derived neurons (T22M, R378G, R498X) to quantify FBXO7 relocation to depolarized mitochondria and Parkin recruitment kinetics, dissecting how each mutation impairs mitophagy.

Deep Research

Falcon

(FBXO7-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Pn Notes

(FBXO7-pn-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)